Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia. Veritas-Pro Project
Sponsor: Medtep Inc.
Listed as NCT02582450, this observational or N/A phase trial focuses on Haemophilia and remains ongoing. Sponsored by Medtep Inc., it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Apr 2018 — Jan 2021 [monthly]
Unknown Status
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtep Inc.
- Real Fundación Victoria Eugenia
For direct contact, visit the study record on ClinicalTrials.gov .